Overview
AINIGMA Technologies develops cutting-edge technology to improve everyday medical services. Their flagship product Arkon.health is a customizable EHR and LIMS solution bridging clinical care with research. They also offer maMEDS, which helps patients with e-prescription codes find nearby pharmacies.
Key people
In the news
- Over the past 3 years, we’ve been proud to be part of the NERO project, and in the process we got to experience its results the way many European SMEs will: as end users of the tools on the #NEROMarketplace. Last week in Piraeus, at the NERO #FinalEvent during the #CyberHOT #SummerSchool and the #FinalPlenaryMeeting hosted by the University of Piraeus Research Center (UPRC), we had the chance to look back on that journey. 🛠️ What we took away as a user: ✅ Easy access to practical, ready-to-use cybersecurity solutions in one
- https://lnkd.in/p/dhTcbgrc
- Are you an experienced paediatrician, methodologist or clinical pharmacologist? PRISM is looking for experts to join its Independent Expert Evaluation Panel. 👶🔬 Help shape which paediatric clinical studies are supported across Europe and Canada. PRISM is establishing an Independent Expert Database to support the transparent, high-quality and independent selection of trials through its open calls. We are seeking: ▸Paediatric experts and sub-specialists ▸General paediatricians ▸Methodologists, biostatisticians and clinical
- Shaping the foundations of European Virtual Human Twins at #VHT2026! AINIGMA Technologies joined technical experts and the VHT User Group at the Advanced Virtual Human Twins Platform Annual Event for the Final Requirements Elicitation Session, helping refine the platform’s first release. From vision to implementation, discussions focused on four key building blocks: 🔐 Secure Sign-In & Access Federation 🛡️ Governance, IPR & Security 📦 Federated Data & Model Storage ⚡ Orchestration & Workflow Management As a company
- Translating Research into Long-Term Impact: GENz-trials at the IHI Forum 2026! Throughout the sessions, it was highlighted the critical importance of early integration across industry, academia, regulatory/HTA bodies, and patients, demonstrating how patient co-creation and proactive alignment on care pathways are essential for building faster, more scalable, and truly patient-centric clinical trials. During the Young Researchers Poster Session we share our early findings from GENz-trials synthetic control arm design with the
- https://lnkd.in/p/duPRNW7T
- Η παρουσία μας στο PHARMA point 2026 στη Θεσσαλονίκη ήταν μια σημαντική ευκαιρία να παρουσιάσουμε από κοντά το οικοσύστημα της maMEDS και να συζητήσουμε με φαρμακοποιούς από όλη τη Βόρεια Ελλάδα για το μέλλον της διαχείρισης της φαρμακευτικής αγωγής. Στο επίκεντρο βρέθηκαν το Σύστημα Εξατομικευμένης Δοσολογίας (ΣΕΔ) και τα ψηφιακά εργαλεία της maMEDS, μέσα από τα οποία επιδιώκουμε να ενισχύσουμε τον ρόλο του φαρμακοποιού και να δημιουργήσουμε μια πιο οργανωμένη, συνεχή και ουσιαστική σύνδεση μεταξύ φαρμακείου, φαρμακοποιού και
- https://lnkd.in/p/dQy9jqvv
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.